TECH — Bio-Techne stock price and chart

TECH

Bio-TechneStock · HealthcareS&P 500 Equal Weight 0.2% · Nasdaq Composite 0.02% · S&P 500 0.02% · Russell 1000 0.02% · US Stock Market 0.02% · Russell 3000 0.02%

$72.37-0.06%

as of market close, Sep 18, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDSDDDDDDDDDDDDDDD

20162019202120242026

30.040.050.060.070.080.090.0100.0110.0120.0130.0050.0M$72.37

2026-09-18

Price$72.37

MA20$63.49

MA50$60.32

Vol15.4M

What would $1,000 invested in TECH be worth today? →

TECH returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $72.37
Change YTD: +23.06%
Next earnings: Nov 4, 2026
Market cap: 11.3B2016-09 4.1B2026-09 11.3B+177.8% over the window
Enterprise value: 11.4B
Shares outstanding: 156.8M2016-06 149.2M2026-06 156.8M+5.1% over the window
52W low: $43.20
52W high: $72.62
From 52W high: -0.34%
From 52W low: +67.52%
52W range: 99%
Beta: 1.28

Volume

Rel volume: 1.83×
30D volume: 2.8M
30D $ vol: 198.8M

Fundamentals

Sales (ttm): 1.2B2016-06 499M2026-06 1.2B+143.5% over the window
Sales/share: $7.752016-06 $3.342026-06 $7.75+131.6% over the window
EPS (ttm): $1.162016-06 $0.702026-06 $1.16+65.7% over the window
FCF (ttm): 263.2M2016-06 127.3M2026-06 263.2M+106.8% over the window
FCF/share: $1.682016-06 $0.852026-06 $1.68+96.8% over the window
Book value/share: $13.442016-06 $5.892026-06 $13.44+128.1% over the window
Net margin: 14.97%2016-06 20.9%2026-06 15.0%-28.5% over the window
ROE: 8.63%2016-06 11.9%2026-06 8.6%-27.4% over the window
ROA: 7.03%2016-06 9.2%2026-06 7.0%-24.0% over the window
Debt / equity: 0.09×2016-06 0.102026-06 0.09-8.8% over the window
Current ratio: 4.552016-06 4.692026-06 4.55-3.0% over the window

Growth (CAGR, ttm) · 10Y

Sales: -0.38%2025-06-30 → 2026-06-301.2B → 1.2B (-0.4% total)+2.25%2023-06-30 → 2026-06-301.1B → 1.2B (+6.9% total)+5.47%2021-06-30 → 2026-06-30931M → 1.2B (+30.5% total)+9.31%2016-06-30 → 2026-06-30499M → 1.2B (+143.5% total)
Net income: +147.92%2025-06-30 → 2026-06-3073.4M → 181.9M (+147.8% total)-13.93%2023-06-30 → 2026-06-30285.3M → 181.9M (-36.2% total)+5.31%2021-06-30 → 2026-06-30140.4M → 181.9M (+29.5% total)+5.70%2016-06-30 → 2026-06-30104.5M → 181.9M (+74.1% total)
FCF: +2.60%2025-06-30 → 2026-06-30256.6M → 263.2M (+2.6% total)+6.79%2023-06-30 → 2026-06-30216.1M → 263.2M (+21.8% total)-3.08%2021-06-30 → 2026-06-30307.9M → 263.2M (-14.5% total)+7.54%2016-06-30 → 2026-06-30127.3M → 263.2M (+106.8% total)
Shares: +0.82%2025-06-30 → 2026-06-30155.5M → 156.8M (+0.8% total)-0.29%2023-06-30 → 2026-06-30158.2M → 156.8M (-0.9% total)+0.06%2021-06-30 → 2026-06-30156.3M → 156.8M (+0.3% total)+0.50%2016-06-30 → 2026-06-30149.2M → 156.8M (+5.1% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +152.33%2025-06-30 → 2026-06-30$0.46 → $1.16 (+152.2% total)-12.97%2023-06-30 → 2026-06-30$1.76 → $1.16 (-34.1% total)+5.92%2021-06-30 → 2026-06-30$0.87 → $1.16 (+33.3% total)+5.18%2016-06-30 → 2026-06-30$0.70 → $1.16 (+65.7% total)
Sales/share: -1.18%2025-06-30 → 2026-06-30$7.84 → $7.75 (-1.2% total)+2.54%2023-06-30 → 2026-06-30$7.19 → $7.75 (+7.8% total)+5.40%2021-06-30 → 2026-06-30$5.96 → $7.75 (+30.1% total)+8.76%2016-06-30 → 2026-06-30$3.34 → $7.75 (+131.6% total)
FCF/share: +1.77%2025-06-30 → 2026-06-30$1.65 → $1.68 (+1.8% total)+7.09%2023-06-30 → 2026-06-30$1.37 → $1.68 (+22.8% total)-3.15%2021-06-30 → 2026-06-30$1.97 → $1.68 (-14.8% total)+7.00%2016-06-30 → 2026-06-30$0.85 → $1.68 (+96.8% total)
Book value/share: +8.99%2025-06-30 → 2026-06-30$12.34 → $13.44 (+9.0% total)+2.64%2023-06-30 → 2026-06-30$12.43 → $13.44 (+8.1% total)+6.10%2021-06-30 → 2026-06-30$10.00 → $13.44 (+34.5% total)+8.60%2016-06-30 → 2026-06-30$5.89 → $13.44 (+128.1% total)
Dividend/share: +0.00%2025-06-30 → 2026-06-30$0.32 → $0.32 (+0.0% total)+0.00%2023-06-30 → 2026-06-30$0.32 → $0.32 (+0.0% total)+0.00%2021-06-30 → 2026-06-30$0.32 → $0.32 (+0.0% total)+0.00%2016-06-30 → 2026-06-30$0.32 → $0.32 (+0.0% total)
Price: +36.60%2025-09-18 → 2026-09-18$52.99 → $72.37 (+36.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+0.56%2023-09-18 → 2026-09-18$71.17 → $72.37 (+1.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-11.53%2021-09-17 → 2026-09-18$133.59 → $72.37 (-45.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+10.41%2016-09-16 → 2026-09-18$26.87 → $72.37 (+169.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +37.38%2025-09-18 → 2026-09-18$52.69 → $72.37 (+37.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+1.08%2023-09-18 → 2026-09-18$70.07 → $72.37 (+3.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-11.13%2021-09-17 → 2026-09-18$130.57 → $72.37 (-44.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+11.06%2016-09-16 → 2026-09-18$25.33 → $72.37 (+185.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 62.4×2016-09 40.612026-09 62.40+53.7% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 45.1×2016-09 27.472026-09 45.06+64.0% over the window
Fwd P/E: 31.4×
P/S (ttm)Market cap ÷ TTM revenue.: 9.3×2016-09 7.902026-09 9.34+18.3% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 5.4×2016-09 4.562026-09 5.38+18.0% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 43.1×2016-09 32.532026-09 43.12+32.6% over the window
EV/EBITDA (fy): 32.6×
EV/Sales (ttm): 9.4×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 2.32%2016-06 3.1%2026-06 2.4%-23.7% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 0.44%
Dividend/share (fwd): $0.32
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 156.8M ÷ 155.5M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.82%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.82%) + dividends paid over that year ($49.9M) ÷ market_cap_at(2025-06-30) ($8B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -0.19%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($41.7M) ÷ today's market cap ($11.3B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.37%2016-06 0.0%2026-06 0.4%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $41.7M + TTM dividends $49.9M) ÷ today's market cap ($11.3B). Same caveat as the cash buyback yield.: 0.81%2016-06 1.2%2026-06 0.8%-29.0% over the window

Vs own 10Y history

P/E: 57th
P/OI: 38th
P/S: 39th
P/B: 37th
P/FCF: 38th

Bar = where today’s multiple sits in TECH’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-09-18

-0.06%

+0.35%

+0.21%

+24.91%

YTD

+23.06%

+36.57%

-45.83%

Financial statements

Open full TECH financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-5.94%	+0.04%
JNJ	Johnson & Johnson	-0.41%	-0.09%
ABBV	AbbVie Inc.	+1.95%	-0.02%
MRK	Merck & Co. Inc.	+8.66%	-0.19%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-4.32%	+0.45%
TMO	Thermo Fisher Scientific Inc.	+10.60%	-1.04%
AMGN	Amgen Inc.	-9.32%	+1.55%
GILD	Gilead Sciences Inc.	+4.65%	-0.52%

Bio-Techne (TECH) trades at $72.37 with a live price and an interactive chart covering 37+ years of daily price history, plus key valuation metrics. ChartRow also publishes TECH’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full TECH financial statements →

TECH — Bio-Techne price, chart and key statistics